WaveMan
WaveMan · Company
FCUV · Focus Universal Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

FCUV Focus Universal (FCUV) Insider Trading, Ownership & Congress Trades

Industrials · Industrial instruments for measurement, display, and control · CIK 0001590418
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Focus Universal insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for FOCUS UNIVERSAL INC. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
WANG DESHENG
CEO and Director
BUY
2025-08-15 SEC
1,000
$2.2K
-95.9%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on Sep 18, 2024.
  • +34.1% median (+11.4% mean) 90-day return after 3 previous buys.
  • The trade is 0.0% of the 2,269,800 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and Director WANG DESHENG bought about $2.2K of FCUV on Aug 15, 2025.
WANG DESHENG
CEO and Director
BUY
2025-08-15 SEC
1,000
$2.2K
-95.9%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on Sep 18, 2024.
  • +34.1% median (+11.4% mean) 90-day return after 3 previous buys.
  • The trade is 0.0% of the 2,264,800 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and Director WANG DESHENG bought about $2.2K of FCUV on Aug 15, 2025.
WANG DESHENG
CEO and Director
BUY
2025-08-15 SEC
1,000
$2.2K
-95.9%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on Sep 18, 2024.
  • +34.1% median (+11.4% mean) 90-day return after 3 previous buys.
  • The trade is 0.0% of the 2,265,800 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and Director WANG DESHENG bought about $2.2K of FCUV on Aug 15, 2025.
WANG DESHENG
CEO and Director
BUY
2025-08-15 SEC
1,000
$2.3K
-95.9%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on Sep 18, 2024.
  • +34.1% median (+11.4% mean) 90-day return after 3 previous buys.
  • The trade is 0.0% of the 2,266,800 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and Director WANG DESHENG bought about $2.3K of FCUV on Aug 15, 2025.
WANG DESHENG
CEO and Director
BUY
2025-08-15 SEC
1,000
$2.2K
-95.9%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on Sep 18, 2024.
  • +34.1% median (+11.4% mean) 90-day return after 3 previous buys.
  • The trade is 0.0% of the 2,270,800 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and Director WANG DESHENG bought about $2.2K of FCUV on Aug 15, 2025.
26 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 21 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-35.9% year over year
below 96% of Industrials
Margin
no margin: no revenue reported
Buybacks
$354.1K repurchased, FY to 2026-06-30
below 95% of Industrials
Short interest
5.2% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
more than 60% of Industrials
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch FCUV

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-97.8%12M
-99%-60%-20%+19%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns FCUV: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in FCUV

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

FCUV planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Dr. Desheng Wang
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$147.9K
$120.0K
$204.6K
-98%
n/a
2024
$170.6K
$120.0K
$204.7K
-92%
n/a
2023
$229.2K
$122.3K
$222.1K
-66%
n/a
2022
$141.0K
$120.0K
$160.0K
-27%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
AXONTMOROKPKOHOFLXXPELSYMLIIITRIWABSNASXI

FCUV financials

Revenue growth
-35.9%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$752.6K
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Free cash flow, TTM
-$11.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
2.20x
long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end); equity 2026-06-30
Cash flow to debt
-0.24x
TTM operating cash flow over long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end)
Return on equity
-106.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-44.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-48.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$15.2M
market value at close 2026-10-26 on 2026-08-10 shares, plus long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end), minus cash 2024-09-30
FCF yield
-442.3%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$255.0K$398.1K$1.1M$353.6K
Gross profit-$35.3K$10.2K$59.7K$22.7K
Operating income-$4.9M-$6.2M-$5.0M-$5.2M
Net income-$4.8M-$3.2M-$4.7M-$4.9M
EPS (diluted)-7.07-4.77-0.78-0.08
Operating cash flow-$5.1M-$4.7M-$3.5M-$3.0M
Buybacks$494.4K$669.9K$1.4M$1.0M
SEC XBRL, fiscal years, as known on 2026-10-28

FCUV Stock Sonar score 4/7 axes

Find similar shapesCompare

FCUV ranks highest on risk and compliance (52nd percentile) and financial health (10th), and lowest on growth (4th), among Industrials peers.

Profitability
9
Inputs
  • Return on equity-106.0% · 6 pct, sector of 198
  • Return on assets-44.2% · 11 pct, sector of 224
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-48.9% · 9 pct, sector of 195
Financial health
10
Inputs
  • Debt to equity2.20x · 4 pct, sector of 214
  • Cash flow to debt-0.24x · 15 pct, sector of 173
Growth
4
Inputs
  • Revenue growth, YoY-35.9% · 4 pct, sector of 254
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
52
Inputs
  • Short interest, % of float+5.2% · 39 pct, sector of 269
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+8.4% · 65 pct, sector of 197
3 not measured: Insider conviction, Institutional and government, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies